Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Summit acquires Dallas Research Institute to expand network

PRIVATESep 10, 2026about 2 hours ago

Acquiring Company

Summit Clinical Research Solutions

Acquired Company

Dallas Research Institute

San AntonioFort WorthBiotechnologyHealth CareBiotechnologyHealth Care

Description

Summit Clinical Research Solutions has acquired Dallas Research Institute to enhance its Pinnacle site network. This acquisition focuses on metabolic and liver diseases, strengthening Summit's presence in the Dallas-Fort Worth area. DRI specializes in complex clinical trials and has been recognized for its exceptional capabilities. The move is expected to deepen the collaboration in clinical research and patient care.

Company Information

Company

Summit Clinical Research Solutions

Location

San Antonio, Texas, United States

About

Summit is an integrated clinical research organization delivering high-quality execution across the clinical trial lifecycle. It helps sponsors accelerate and optimize clinical development through a robust site network and specialized services. Founded in 2018, Summit has supported numerous sponsors across clinical trials with a strong focus on metabolic diseases. Its platform includes over 110 partner sites globally.

Don't miss Summit Clinical Research Solutions's next move

Get an email the moment Summit Clinical Research Solutions makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Summit Clinical Research Solutions's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Dallas Research Institute?

Dallas Research Institute was acquired by Summit Clinical Research Solutions, based in San Antonio. The deal was reported on September 10, 2026. Summit is an integrated clinical research organization delivering high-quality execution across the clinical trial lifecycle. Summit Clinical Research Solutions is privately held and operates in Biotechnology.

When did Summit Clinical Research Solutions acquire Dallas Research Institute?

Summit Clinical Research Solutions's acquisition of Dallas Research Institute was reported on September 10, 2026. Summit Clinical Research Solutions has acquired Dallas Research Institute to enhance its Pinnacle site network. This acquisition focuses on metabolic and liver diseases, strengthening Summit's presence in the Dallas-Fort Worth area. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Dallas Research Institute do?

DRI is a clinical research site specializing in complex clinical trials targeting metabolic diseases such as MASH and MASLD. It is privately held, operating in Biotechnology, and is based in Fort Worth.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.